+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Cancer Care"

From
From
From
Antibody Drug Conjugate - Competitive Landscape, 2026 - Product Thumbnail Image

Antibody Drug Conjugate - Competitive Landscape, 2026

  • Report
  • April 2026
  • 280 Pages
  • Global
From
From
From
Checkpoint Inhibitors - Competitive Landscape, 2026 - Product Thumbnail Image

Checkpoint Inhibitors - Competitive Landscape, 2026

  • Report
  • January 2026
  • 180 Pages
  • Global
From
CAR T - Cell Therapy - Competitive Landscape, 2026 - Product Thumbnail Image

CAR T - Cell Therapy - Competitive Landscape, 2026

  • Report
  • January 2026
  • 500 Pages
  • Global
From
Chemotherapy Induced Pain Epidemiology Forecast 2026-2035 - Product Thumbnail Image

Chemotherapy Induced Pain Epidemiology Forecast 2026-2035

  • Report
  • May 2026
  • 150 Pages
  • Global
From
TCR Therapy Drug Pipeline Analysis Report 2026 - Product Thumbnail Image

TCR Therapy Drug Pipeline Analysis Report 2026

  • Drug Pipelines
  • May 2026
  • 150 Pages
  • Global
From
Oncology Drugs Market 2026-2030 - Product Thumbnail Image

Oncology Drugs Market 2026-2030

  • Report
  • August 2026
  • 316 Pages
  • Global
From
From
From
From
From
From
From
From
From
Loading Indicator

The Cancer Care market within the context of Oncology Drugs is a rapidly growing industry. It is composed of a variety of products and services, including drugs, diagnostics, and treatments. Oncology drugs are used to treat cancer, and they can be divided into two categories: targeted therapies and immunotherapies. Targeted therapies are designed to target specific cancer cells, while immunotherapies are designed to boost the body's own immune system to fight cancer. Both types of drugs are used to treat a variety of cancers, including breast, lung, and colorectal cancer. The Cancer Care market is highly competitive, with many companies vying for market share. Companies in the market include AstraZeneca, Bristol-Myers Squibb, Eli Lilly, Merck, Novartis, Pfizer, and Roche. These companies are all involved in the development, manufacture, and marketing of oncology drugs. Additionally, there are many smaller companies that specialize in the development of new treatments and therapies. Show Less Read more